Skip to main content


(CLPT) - Get ClearPoint Neuro, Inc. Report

was up 6.9% in early afternoon after

Robertson Stephens

Scroll to Continue

TheStreet Recommends

began coverage of the company with a buy rating and a 12-month price target of $15.

Robertson Stephens said CellPoint, a maker of wireless locator technology, is a good bet for investors with a two- to four-year perspective.